ERNA:NASDAQ
Ernexa Therapeutics Inc
$2.39
0.00%
(0.00) 1D
$2.43
arrow_upward
+1.64% (+0.039)todayPre-market
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ERNA...
Mkt. cap
3.89M
Avg. vol.
65.05K
Volume
44.64K
52-wk high
$71.50
52-wk low
$2.15
EPS
-$18.69
Beta
2.64
Shares outstanding
1.63M
No. of employees
5
Mkt. cap
3.89M
Avg. vol.
65.05K
Volume
44.64K
52-wk high
$71.50
52-wk low
$2.15
EPS
-$18.69
Beta
2.64
Shares outstanding
1.63M
No. of employees
5
News stories
From web sources and news partners
Stock Titan
·
2 days ago
In animal tests, cell therapy plus immune treatment fully controlled ovarian tumors in most animals.
Benzinga
·
2 days ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
About Ernexa Therapeutics Inc
CEO-
Employees5
Founded2018
HeadquartersBrooklyn, New York, United States
SectorBiotechnology
Websiteernexatx.com